Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.030
-0.080 (-1.95%)
At close: Jun 16, 2026, 4:00 PM EDT
4.010
-0.020 (-0.50%)
After-hours: Jun 16, 2026, 6:37 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $235.44 million as of June 16, 2026. Its market cap has increased by 1.29% in one year.
Market Cap
235.44M
Enterprise Value
93.81M
1-Year Change
1.29%
Ranking
Category
Stock Price
$4.03
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $235.44M, a decrease of -58.36%. That is a compound annual growth rate of -14.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 235.44M | -22.90% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 248.15M |
| Sol-Gel Technologies | 241.32M |
| Adagene | 240.50M |
| InflaRx | 238.61M |
| YD Bio | 238.39M |
| Orchestra BioMed Holdings | 237.73M |
| Humacyte | 237.56M |
| Entrada Therapeutics | 236.92M |